Tag : OnTrack

CCT Impact

PAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On Track

PAO Group, Inc. (USOTC: PAOG) today announced a management update on the company’s ongoing CBD Pharmaceutical Development Program progress scheduled to be released next week on Tuesday, April 13, 2021. Last year, PAOG acquired RespRx from Kali-Extracts, Inc. (OTC Pink: KALY). RespRx is a CBD treatment under development for Chronic Obstructive......